18: Propensity Score-Based Stratified Win Ratio for Augmented Control Designs

Joon Jin Song Co-Author
Baylor University
 
Yingdong Feng Co-Author
Eli Lilly and Company
 
Michael Sonksen Co-Author
 
Tuo Wang Co-Author
Eli Lilly and Company
 
Yurong Chen First Author
Baylor University
 
Yurong Chen Presenting Author
Baylor University
 
Monday, Aug 4: 10:30 AM - 12:20 PM
1732 
Contributed Posters 
Music City Center 
This project proposes a propensity score (PS)-based stratified win ratio method to address challenges of small patient populations in clinical trials, especially for rare or pediatric diseases, by incorporating external control data. Our approach enhances traditional win ratio analysis by leveraging PS stratification to account for heterogeneity between the current and external studies. Additionally, down-weighting based on the overlapping coefficient of PS distributions of current treatment and external control groups further mitigates the patient bias due to heterogeneity. Our simulations showed significant improvements in statistical power for detecting treatment effects within the composite endpoint, over non-borrowing and pooling methods, with utilizing Mantel-Haenszel (MH)-type weights achieving the highest power. The proposed methods are also applied to an Amyotrophic Lateral Sclerosis (ALS) study incorporating the external control arm from a prior ALS trial. The proposed PS-based stratified win ratio method thus provides a rigorous framework for borrowing external data and analyzing composite endpoints with limited patient availability.

Keywords

Placebo borrowing

Win ratio

Composite endpoint analysis

Propensity score stratification 

Abstracts


Main Sponsor

Biometrics Section